Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Gastroenterology --- Liver Cirrhosis --- Cirrhosis, Liver --- Fibrosis, Liver --- Hepatic Cirrhosis --- Liver Fibrosis --- Cirrhosis, Hepatic --- Congresses --- Conferences - Meetings

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact

Medicine --- Immunology --- Liver Fibrosis --- Liver immune response --- Bacteria and liver --- Parasite and liver --- Virus and liver

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

In recent years there have been huge advances in the understanding of the genetic and molecular basis of the fibrocystic diseases. This volume provides a thorough review of fibrocyctic diseases that affect the liver. It contains in-depth discussions of the genetics, molecular biology, pathogenesis, histology, clinical presentations, complications of, treatment, and prognosis of the conditions affecting children and adults, and hence will be the gold-standard reference for these conditions. In addition, the histological features that distinguish these conditions from other potentially fibrosing hepatopathies are illustrated. Conditions with syndromic features involving the kidney or other organ systems are also reviewed. Thorough review of the clinical phenotypes, their presentations, treatment, potential complications of, and prognosis is discussed. Fibrocystic Diseases of the Liver will be an invaluable resource for hepatologists, gastroenterologists, nephrologists, and hepatic surgeons who care for children and adults with liver disease, as well as basic scientists in molecular genetics, hepatobiliary pathophysiology, hepatology and nephrology.

Liver -- Diseases. --- Liver -- Fibrosis. --- Liver --- Liver Cirrhosis --- Liver Diseases --- Digestive System Diseases --- Diseases --- Gastroenterology --- Medicine --- Health & Biological Sciences --- Fibrosis --- Fibrosis. --- Diseases. --- Medicine. --- Gastroenterology. --- Hepatology. --- Nephrology. --- Pediatrics. --- Abdominal surgery. --- Medicine & Public Health. --- Abdominal Surgery. --- Abdomen --- Biliary tract --- Clinical medicine. --- Surgery. --- Medicine, Clinical --- Internal medicine --- Digestive organs --- Abdominal surgery --- Laparotomy --- Paediatrics --- Pediatric medicine --- Children --- Kidneys --- Health and hygiene --- Gastroenterology .

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The purpose of this Special Issue is to provide a thorough and up-to-date presentation of research investigating the impact of coffee and/or caffeine intake on various health outcomes. Areas of interest include, but are not limited to, the following topics: Human clinical trials of coffee or caffeine use in relation to disease or intermediate phenotypes. Epidemiological studies of habitual coffee or caffeine intake in relation to human health, among the general public, as well as, among special populations (i.e., children, pregnant women, diabetics, cancer patients, hypertensives, etc.). Mechanisms of action of nutrients and other bioactive components of coffee/caffeine. Studies integrating genetic or physiological markers of coffee/caffeine intake to investigations of coffee and health.

coronary artery disease --- n/a --- lipids --- NADH dehydrogenase --- tea --- tinnitus --- safety --- transcriptomics --- ergogenic --- guidelines --- myocardial perfusion --- placebo --- Caffeine --- risk factors --- lysophosphatidylcholine --- pregnancy --- assisted reproduction techniques --- population --- adenosine --- liver fibrosis --- coffee consumption --- cognitive --- causation --- supplement --- mate --- adult --- gene expression --- wine --- lipidomics --- chocolate --- exercise --- protection --- Suicide --- dipyridamole --- regadenoson --- live birth --- hearing --- pharmacological ergogenic aid --- behavior --- cardiovascular disease --- gene-diet interaction --- whole-blood --- sex --- health --- systematic review --- causality --- genetic epidemiology --- implantation --- pharmacogenomics --- cognitions --- ergogenic aid --- time trial performance --- CYP1A2 --- aging --- phenolic --- country --- caffeine intake --- serum chloride levels --- polymorphism --- responders --- intoxication --- trial --- epidemiological methods --- bias --- adenosine receptor --- longevity --- did not respond --- energy drinks --- biomarkers --- individual responses --- Mendelian Randomization --- public policy --- anxiety --- the Norwegian Women and Cancer Cohort (NOWAC) --- ADORA2A --- clinical pregnancy --- caffeine metabolism --- caffeine intoxication --- cohort study --- mood --- mRNA --- alcohol consumption --- epidemiology --- caffeine --- expectancy --- accidental death --- European Prospective Investigation into Cancer and Nutrition --- cognition --- consumption --- HIV-HCV co-infection --- cytochrome P450 --- chlorogenic acids --- soda --- 24-h dietary recall --- coffee --- depression --- sport --- age

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Gastrointestinal (GI) cancer is a major cause of morbidity and mortality in the world. Since early diagnosis and optimal treatment selection are crucial to improving the prognosis of these diseases, the discovery of useful biomarkers has the potential to greatly reduce their burden. Recent technical and mechanical developments have allowed for the detection of tiny differences in various factors modified in physical conditions, which could contribute to the discovery of novel biomarkers for some diseases.In this Special Issue, we aim to focus on novel biomarkers for GI cancers, including esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer and biliary cancer. In addition, any samples (tissue, blood, urine and feces) are useful as biomarker sources, although body-fluid-based biomarkers are promising as diagnostic biomarkers due to their noninvasiveness. This Special Issue aims to collect novel insights clarifying the current situation and future perspective in this field.

Medicine --- Oncology --- colorectal cancer --- advanced adenoma --- screening --- stool --- mRNA --- n/a --- cancer screening --- cirrhosis --- AFP --- machine learning --- MALDI-TOF --- proteomics --- CXCR4 --- prognosis --- overall survival --- rectal cancer --- neoadjuvant chemoradiation --- mouse model --- biomarkers --- urokinase plasminogen activator (uPA) --- urokinase plasminogen activator receptor (uPAR) --- plasminogen activator inhibitor type 1 (PAI-1) --- circulating tumour cell (CTC) --- gastric cancer --- oesophageal cancer --- serine proteases --- tumour microenvironment --- serpins --- biomarker --- chemoresistance --- liquid biopsy --- microRNA --- long non-coding RNA --- colorectal neoplasms --- cancer screening tests --- early detection of cancer --- precision medicine --- unfolded protein --- hepatocellular cancer --- GSVA --- unfolded protein score --- epigenetic regulation genes --- somatic mutations --- molecular genetic markers --- extracellular vesicles --- microbiome --- 16S rRNA amplicon --- metagenomics --- liver fibrosis --- hepatocellular carcinoma --- recurrence --- SHG/TPEF microscopy --- artificial intelligence --- advanced gastric cancer --- targeted therapy --- urinary miRNA --- miR-129-1-3p --- miR-566